Table 1.
Mitogens and concentrations used throughout the experiments
| Mitogen | Concentration |
|---|---|
| PHA (PHA-L, Sigma Aldrich, St Louis, MO, USA) | 5 µg/ml |
| αCD3 (Orthoclon OKT3, Ortho Biotech Products, Raritan, NJ, USA) | 12.5 ng/ml (soluble) |
| αCD3 (Orthoclon OKT3, Ortho Biotech Products, Raritan, NJ, USA) | 1 µg/ml (plastic-bound) |
| αCD2 (T11 1/1, clone 6G4, and 2/1, clone 4B2) (CLB, Amsterdam, The Netherlands) | 2.5 µg/ml |
| αCD28 (KOLT-2) (CLB, Amsterdam, The Netherlands) | 50 ng/ml |
| PMA (Sigma Aldrich) | 10 ng/ml when used alone, 1.2 ng/ml when combined with ionomycin |
| Ionomycin (Calbiochem, La Jolla, CA, USA) | 1 µM |
| IL-2 (rhIL-2, TECIN, Hoffman-La Roche, Newton, NJ, USA) | 50 U/ml |